Skip to content
★ Sign in to follow
Aptus Pharma logo

Aptus Pharma Stock: price and insider trades · India

IN·Mcap ₹6.1B

Aptus Pharma: what insiders have been doing

Every trade that managers of Aptus Pharma disclose to SEBI (PIT + SAST) is tracked on this page. The last twelve months, up to 9 November 2026, brought 9 filings signed by 9 insiders.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

No insider has bought Aptus Pharma shares on the open market in the past twelve months. Most trades are made public on the day they happen. That lag is the time during which only the insider knows about the trade.

Across the 1,986 companies tracked on its exchange, the median is 4 filings; at 9 filings, this issuer sits above that mark.

Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.

Insider Decl.
9
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 11,645 of 26,913 companies
55.1
score / 100
Value
34
Quality
76
FCF yld-0.9%
Earn yld0.6%
EV/EBITDA·
ROE30%
Gross mgn49%
Net mgn9.9%
Debt/EBITDA1.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹353.25
Analyst consensus
·
Income statement
Revenue₹465.7M
Gross profit₹229.9M49% margin
EBITDA₹75.1M16% margin
Net income₹46.2M9.9% margin
Valuation
PER (trailing)113.6x
P/Book25.9x
Balance sheet & cash
Market cap₹6.1B
Total debt₹71.8M
Free Cash Flow-₹77.9M
Debt / Equity31%
Profitability & ownership
ROE30.5%
ROA13.5%
% insiders72.9%
% institutions0.0%
Last declaration on 27 May 2026
Declarations9 total
  • ●
    PromoterExecutives
    0SEBI
    18,000 shares-Off Market / Inter se transferSEBI:423e5f2be296c63c931ba9ae0141c1266ad841f2
  • ●
    PromoterExecutives
    0SEBI
    18,000 shares-Off Market / Inter se transferSEBI:17396e9863e3c067d7baf4516175fc4f5e64be05
  • ●
    PromoterExecutives
    0SEBI
    18,000 shares-Off Market / Inter se transferSEBI:bfc89f069546509dba3aff0159d2705a7668f0f7
  • ●
    PromoterExecutives
    0SEBI
    18,000 shares-Off Market / Inter se transferSEBI:d1aa3891d68ba2438f6cdc7d3e85d61a2790c513
  • ●
    PromoterExecutives
    0SEBI
    10,000 shares-Off MarketSEBI:d70be3c792fe6af3df1fb6f7efcded9e07dc98fa
  • ●
    PromoterExecutives
    0SEBI
    10,000 shares-Off MarketSEBI:2d5b6703295bad7515c458e7c1260d19228443a1
  • ●
    PromoterExecutives
    0SEBI
    124,000 shares-Off Market / Inter se transferSEBI:fda5817aef0a473c7f64a2af4ed7a0653cc45033
  • ●
    PromoterExecutives
    0SEBI
    18,000 shares-Off Market / Inter se transferSEBI:ed640d7f7530313e08c786e8ab54850109d9fbe6
  • ●
    PromoterExecutives
    0SEBI
    14,000 shares-Off Market / Inter se transferSEBI:9f066b31472de6cab9b3c4f066474312ce5ecda3

9 of 9 declarations

About Aptus Pharma

Aptus Pharma is a pharmaceutical company focused on developing innovative solutions for the healthcare sector. It is listed on the XBOM market.